Mytos

0 reviews

Mytos is revolutionizing regenerative medicine by providing automated manufacturing solutions that enable scalable, consistent, and cost-effective production of cell-based therapies. Their proprietary iDEM™ technology automates all unit operations in cell culture, including coating, seeding, feeding, imaging, passaging, and harvesting, while maintaining the biological integrity of the cells. This automation reduces labor per batch by up to tenfold and minimizes cleanroom footprint, ensuring consistent quality at scale and reducing the risk of operator-related batch failures. By integrating iDEM™ into their Contract Development and Manufacturing Organization (CDMO) services, Mytos offers a comprehensive, one-stop solution that handles every aspect of manufacturing—from process and analytical development to regulatory support—without hidden costs or the need for device purchases. This approach allows biotech companies to avoid delays associated with hiring and training, preserve financial runway, and achieve up to 50% cost reduction compared to manual CDMOs. Ultimately, Mytos empowers the regenerative medicine industry to bring life-saving therapies to millions of patients more efficiently and affordably.